Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
I was initially a little concerned that my resting heart rate increased by almost 20 bpm
November 2024 Wegovy Lawsuit Update Given common questions of fact and law raised in a growing number of the claims now being pursued by former users of Wegovy, Ozempic and similar medications, all federal GLP-1 lawsuits have been centralized as part of an MDL, or multidistrict litigation, where U.S
Mechanisms hypothesised to underlie blood pressure reduction with tirzepatide include: Weight reduction : Loss of adipose tissue decreases sympathetic nervous system activity, reduces cardiac output, and improves insulin sensitivityall contributing to lower blood pressure Natriuresis : GLP-1 receptor activation may promote sodium excretion through renal effects, though direct evidence for tirzepatide is limited Improved endothelial function : Weight loss and metabolic improvements may enhance vascular health Reduced inflammation : Adipose tissue reduction decreases pro-inflammatory cytokines that may contribute to hypertension It is important to note that whilst the blood pressure reductions are consistent across trials, tirzepatide is not licensed as an antihypertensive agent
Any disease driven by a harmful protein trapped inside the cell, from certain cancers to some forms of dementia, could one day become a target
Slows intestinal motility Lowers blood sugars, in part by reducing the production of sugar in the liver Decreases carbohydrate and sugar cravings You are NOT a good candidate for semaglutide if you have any of the following: diabetic retinopathy, decreased kidney function, pancreatitis, medullary thyroid cancer (or a family history of medullary thyroid carcinoma), or multiple endocrine neoplasia type 2
